Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of “Hold” by Analysts

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have earned a consensus rating of “Hold” from the twenty-three analysts that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a sell recommendation, fifteen have issued a hold recommendation, three have issued a buy recommendation and one has issued […]

Leave a Reply

Your email address will not be published.

Previous post South Korea April 2025: New gen pushes Hyundai Palisade to #5, Kia EV4 lands
Next post Q3 Earnings Estimate for Blue Bird Issued By DA Davidson